| Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application. | Int J Mol Sci | 2018 Jan 16 | 29337925 |
| Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). | Lancet | 2017 Oct 7 | 28756902 |
| Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines. | Int J Pharm | 2016 Jun 15 | 27107899 |
| Natural products induce a G protein-mediated calcium pathway activating p53 in cancer cells. | Toxicol Appl Pharmacol | 2015 Nov 1 | 26341291 |
| Alpha-carotene inhibits metastasis in Lewis lung carcinoma in vitro, andsuppresses lung metastasis and tumor growth in combination with taxol in tumorxenografted C57BL/6 mice. | J Nutr Biochem | 2015 Jun | 25736483 |
| Plant diterpene synthases: exploring modularity and metabolic diversity forbioengineering. | Trends Biotechnol | 2015 Jul | 26003209 |
| Enhancing Activity of Anticancer Drugs in Multidrug Resistant Tumors byModulating P-Glycoprotein through Dietary Nutraceuticals. | Asian Pac J Cancer Prev | 2015 | 26514453 |
| Improvement of hairy root cultures and plants by changing biosynthetic pathways leading to pharmaceutical metabolites: strategies and applications. | Biotechnol Adv | 2014 Nov 1 | 24699436 |
| Novel action modality of the diterpenoid anisomelic acid causes depletion of E6and E7 viral oncoproteins in HPV-transformed cervical carcinoma cells. | Biochem Pharmacol | 2014 May 15 | 24565908 |
| Systemic toxicity induced by paclitaxel in vivo is associated with the solvent cremophor EL through oxidative stress-driven mechanisms. | Food Chem Toxicol | 2014 Jun | 24657178 |